|
Volumn 57, Issue 2, 2002, Pages 83-86
|
Drug therapy in asthma bronchiale in the new millennium
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADENOSINE A2B RECEPTOR ANTAGONIST;
ADENOSINE A3 RECEPTOR AGONIST;
ADENOSINE RECEPTOR BLOCKING AGENT;
ADENOSINE RECEPTOR STIMULATING AGENT;
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
BRADYKININ B2 RECEPTOR ANTAGONIST;
CHLORIDE CHANNEL BLOCKING AGENT;
CROMOGLYCATE DISODIUM;
CYSTEINYLLEUKOTRIENE ANTAGONIST;
CYTOKINE INHIBITOR;
FORSKOLIN;
FUROSEMIDE;
GLUCOCORTICOID;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR BLOCKER;
HISTAMINE H1 RECEPTOR ANTAGONIST;
IMMUNOGLOBULIN E ANTIBODY;
INTERLEUKIN 10 RECEPTOR AGONIST;
INTERLEUKIN 4;
INTERLEUKIN 4 RECEPTOR ANTAGONIST;
INTERLEUKIN 5;
INTERLEUKIN 5 RECEPTOR ANTAGONIST;
LOTEPREDNOL ETABONATE;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY IGE;
MUSCARINIC M3 RECEPTOR ANTAGONIST;
PEPTIDOLEUKOTRIENE;
PHOSPHODIESTERASE INHIBITOR;
POTASSIUM CHANNEL AFFECTING AGENT;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
URODILATIN;
ALLERGY;
ASTHMA;
DRUG DESIGN;
DRUG METABOLISM;
PATHOGENESIS;
PROMOTER REGION;
REVIEW;
SIGNAL TRANSDUCTION;
TH1 CELL;
TH2 CELL;
ANIMALS;
ANTI-ASTHMATIC AGENTS;
ASTHMA;
CELL MEMBRANE;
CELL NUCLEUS;
CYTOSOL;
HUMANS;
SIGNAL TRANSDUCTION;
|
EID: 0036174939
PISSN: 00317144
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (6)
|
References (35)
|